Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review-Reference-Cited by-同舟云学术

Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review

Published:2023-03-01 Issue:2 Volume:39 Page:89-101
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Perez Victor L.¹,Mah Francis S.²,Willcox Mark³,Pflugfelder Stephen⁴

Affiliation:

1. Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, North Carolina. USA.

2. Scripps Clinic Torrey Pines, La Jolla, California, USA.

3. School of Optometry and Vision Science, UNSW Sydney, Sydney, New South Wales, Australia.

4. Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2022.0133

Reference147 articles.

1. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older

2. The global prevalence of dry eye disease: A Bayesian view

3. TFOS DEWS II Sex, Gender, and Hormones Report

4. TFOS DEWS II Epidemiology Report

5. The Pathophysiology of Dry Eye Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin inhibits hypertonicity-induced inflammatory injury in human corneal epithelial cells via the PTEN/PI3K/AKT pathway;Tissue and Cell;2024-08

2. Melatonin alleviates high-fat-diet-induced dry eye by regulating macrophage polarization via IFT27 and lowering ERK/JNK phosphorylation;iScience;2024-07

3. Novel treatments for dry eye syndrome;Current Opinion in Pharmacology;2024-04

4. Therapeutic Applications of Artemisinin in Ophthalmic Diseases;2024

5. Unveiling the Power of Gabapentin-Loaded Nanoceria with Multiple Therapeutic Capabilities for the Treatment of Dry Eye Disease;ACS Nano;2023-12-05